TAP
60
2
KEY
31
2
TROW
50
2
VZ
39
2
LEN
45
3
PDCO
74
-3
ORCL
52
-7
RF
47
3
NDAQ
50
-6
VRSK
63
-3
NKE
37
-3
EA
50
-2
AIV
65
-6
ADI
57
-2
FSLR
63
5
AKAM
59
-2
XEL
53
-2
HAS
32
-5
KMX
66
-2
AVGO
88
27
TAP
60
2
KEY
31
2
TROW
50
2
VZ
39
2
LEN
45
3
PDCO
74
-3
ORCL
52
-7
RF
47
3
NDAQ
50
-6
VRSK
63
-3
NKE
37
-3
EA
50
-2
AIV
65
-6
ADI
57
-2
FSLR
63
5
AKAM
59
-2
XEL
53
-2
HAS
32
-5
KMX
66
-2
AVGO
88
27
Financhill
Back

Amneal Pharmaceuticals Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
47

AMRX
Amneal Pharmaceuticals

Last Price:
7.83
Seasonality Move:
-2.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Amneal Pharmaceuticals Price Quote

$7.83

Amneal Pharmaceuticals Key Stats

Sell
47
Amneal Pharmaceuticals (AMRX) is a Sell
Day range:
$7.76 - $7.95
52-week range:
$4.91 - $9.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.86
P/B ratio:
0%
Volume:
735K
Avg. volume:
1.2M
1-year change:
66.24%
Market cap:
$2.4B
Revenue:
$2.4B
EPS:
$-0.68

How Much Does Amneal Pharmaceuticals Make?

Is Amneal Pharmaceuticals Growing As A Company?

Amneal Pharmaceuticals Stock Price Performance

What Is Amneal Pharmaceuticals 52-Week High & Low?

Amneal Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Amneal Pharmaceuticals?

Is Amneal Pharmaceuticals Cash Flow Positive?

  • What Is AMRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $312.8M
  • What Is Amneal Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$251.4M
  • What Is Amneal Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$78.6M

Amneal Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMRX return on invested capital is -6.95%
  • What Is Amneal Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -5.24%
  • What Is AMRX Return On Equity?
    ROE is a measure of profitability and is -587.3%

Amneal Pharmaceuticals Earnings Date & Stock Price

Amneal Pharmaceuticals Competitors

Amneal Pharmaceuticals Dividend Yield

Amneal Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.3%
Revenue: 13.29% 1.26%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.50
Upside from Last Price: 34.1%

Major Shareholders

  • How many AMRX shares are owned by institutional investors?
    184.8M AMRX shares are owned by institutional investors
  • How many AMRX shares are owned by insiders?
    7.4M AMRX shares are owned by insiders